| Safety concerns over the use of intestinal permeation enhancers: A mini-review F McCartney, JP Gleeson, DJ Brayden Tissue barriers 4 (2), e1176822, 2016 | 128 | 2016 |
| Labrasol® is an efficacious intestinal permeation enhancer across rat intestine: ex vivo and in vivo rat studies F McCartney, V Jannin, S Chevrier, H Boulghobra, DR Hristov, N Ritter, ... Journal of controlled release 310, 115-126, 2019 | 81 | 2019 |
| Physicochemical, pharmacokinetic and pharmacodynamic analyses of amphiphilic cyclodextrin-based nanoparticles designed to enhance intestinal delivery of insulin E Presas, F McCartney, E Sultan, C Hunger, S Nellen, CV Alvarez, ... Journal of controlled release 286, 402-414, 2018 | 51 | 2018 |
| Effects of surfactant-based permeation enhancers on mannitol permeability, histology, and electrogenic ion transport responses in excised rat colonic mucosae S Maher, J Heade, F McCartney, S Waters, SB Bleiel, DJ Brayden International Journal of Pharmaceutics 539 (1-2), 11-22, 2018 | 41 | 2018 |
| Evaluation of sucrose laurate as an intestinal permeation enhancer for macromolecules: ex vivo and in vivo studies F McCartney, M Rosa, DJ Brayden Pharmaceutics 11 (11), 565, 2019 | 33 | 2019 |
| Silica-Coated Nanoparticles with a Core of Zinc, l-Arginine, and a Peptide Designed for Oral Delivery D Hristov, F McCartney, J Beirne, E Mahon, S Reid, S Bhattacharjee, ... ACS applied materials & interfaces 12 (1), 1257-1269, 2019 | 32 | 2019 |
| Comparison of the effects of the intestinal permeation enhancers, SNAC and sodium caprate (C10): Isolated rat intestinal mucosae and sacs C Twarog, F McCartney, SM Harrison, B Illel, E Fattal, DJ Brayden European Journal of Pharmaceutical Sciences 158, 105685, 2021 | 27 | 2021 |
| Striving towards the perfect in vitro oral drug absorption model JP Gleeson, F McCartney Trends in pharmacological sciences 40 (10), 720-724, 2019 | 22 | 2019 |
| An enteric-coated polyelectrolyte nanocomplex delivers insulin in rat intestinal instillations when combined with a permeation enhancer S Sladek, F McCartney, M Eskander, DJ Dunne, MJ Santos-Martinez, ... Pharmaceutics 12 (3), 259, 2020 | 19 | 2020 |
| Impact of PEGylation on an antibody-loaded nanoparticle-based drug delivery system for the treatment of inflammatory bowel disease N Shrestha, Y Xu, JRC Prévost, F McCartney, D Brayden, R Frédérick, ... Acta biomaterialia 140, 561-572, 2022 | 14 | 2022 |
| Barriers to the intestinal absorption of four insulin-loaded arginine-rich nanoparticles in human and rat P Lundquist, G Khodus, Z Niu, LN Thwala, F McCartney, I Simoff, ... ACS nano 16 (9), 14210-14229, 2022 | 10 | 2022 |
| Permeability-enhancing effects of three laurate-disaccharide monoesters across isolated rat intestinal mucosae F McCartney, DR Perinelli, M Tiboni, R Cavanagh, S Lucarini, GF Palmieri, ... International Journal of Pharmaceutics 601, 120593, 2021 | 7 | 2021 |
| The UCD nanosafety workshop (03 December 2018): towards developing a consensus on safe handling of nanomaterials within the Irish university labs and beyond–a report V Stuttgen, HE Giffney, A Anandan, A Alabdali, C Twarog, SA Belhout, ... Nanotoxicology 13 (6), 717-732, 2019 | 6 | 2019 |
| Synthesis and in vivo evaluation of insulin-loaded whey beads as an oral peptide delivery system J Heade, F McCartney, M Chenlo, OM Marro, M Severic, R Kent, SB Bleiel, ... Pharmaceutics 13 (5), 656, 2021 | 5 | 2021 |
| Safety concerns over the use of intestinal permeation enhancers: a mini-review. Tissue Barriers 4, e1176822 F McCartney, JP Gleeson, DJ Brayden | 5 | 2016 |
| Cystic ovary disease impairs transport speed, smooth muscle contraction, and epithelial ion transport in the bovine oviduct DM Scully, D Campion, F McCartney, K Dulohery, S Reese, S Kölle Molecular Reproduction and Development 88 (8), 558-570, 2021 | 3 | 2021 |
| Challenges in permeability assessment for oral drug product development M Koziolek, P Augustijns, C Berger, R Cristofoletti, D Dahlgren, J Keemink, ... Pharmaceutics 15 (10), 2397, 2023 | 2 | 2023 |
| Insulin-containing silica nanoparticles with a high loading capacity and demonstration of bioactivity: potential for oral delivery D Hristov, F McCartney, J Beirne, S Reid, E Mahon, S Bhattacharjee, ... ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 256, 2018 | 1 | 2018 |
| Industry news update: December 2023 F McCartney Therapeutic Delivery, 2024 | | 2024 |
| September industry news update F McCartney Therapeutic Delivery 14 (11), 669-673, 2023 | | 2023 |
David BraydenProfessor of Advanced Drug Delivery, University College DublinVerified email at ucd.ie
